Quality indicators in hemodialysis: A 5‐year experience of national campaigns in France

Abstract

AbstractBackground: End stage kidney disease (ESKD) is associated with increased morbidity and mortality. Hemodialysis (HD) is the main technique used for kidney replacement therapy. Dialyzed patients are expected to live less than one half as long as their counterparts without ESKD. Improving quality of care may help to improve mortality in this population. Methods: The French National Authority for Health has carried out three consecutive national campaigns over 5 years for the assessment of quality indicators (QCI) during HD. QCI included anemia management, iron status evaluation, nutritional status assessment, and annual transplantation access. Results: From 2013 to 2017, 227 health facilities participated, and 33,319 files were analyzed. Median age was 72 years old (IQR25–75 = 61–81), and 58.25% of patients were men. Median time in HD was 39.4 months (IQR25–75 = 20.7–72.7). Most of the patients underwent in‐center HD (85.41%). Overweight and obese patients accounted, respectively, for 28.39% and 21.32%, and malnutrition was present in 38.61%. A contra‐indication for renal transplantation was found in 68.3% of patients. All QCI improved over 5 years. Conclusion: Developing QCI based on guidelines is crucial to assure appropriate care of HD patients. Repeating campaigns over 5 years in France improves the quality of care among physicians.